NCT02064036View on ClinicalTrials.gov

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 6, 2013

Primary Completion Date

December 3, 2020

Study Completion Date

October 29, 2021

Conditions
Adenocarcinoma of the Prostate
Interventions
RADIATION

Stereotactic Radiosurgical Boost

Intensity Modulated Radiotherapy (IMRT)2 with Concurrent Androgen Blockade to Whole Pelvis, Prostate, and Seminal Vesicles Followed by: Stereotactic Radiosurgical Boost3 to the Prostate with Implanted Electromagnetic Transponder Beacon Intrafraction Guidance

DRUG

Casodex

Neoadjuvant Androgen Blockade before radiation therapy and Adjuvant Androgen Blockade after radiation therapy

DRUG

Leuprolide

Neoadjuvant Androgen Blockade before radiation therapy and Adjuvant Androgen Blockade after radiation therapy

Trial Locations (1)

95817

UC Davis Sacramento Cancer Center Dept of Radiation Oncology, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT02064036 - Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate | Biotech Hunter | Biotech Hunter